Community-acquired pneumonia: Difference between revisions
From IDWiki
(→: linkified) |
(→: linkified) |
||
| Line 24: | Line 24: | ||
** [[RSV]] |
** [[RSV]] |
||
** [[Adenovirus]] |
** [[Adenovirus]] |
||
** Human metapneumovirus |
** [[Human metapneumovirus]] |
||
** Middle East respiratory syndrome |
** [[Middle East respiratory syndrome coronavirus]] (MERS-CoV) |
||
** Rhinovirus |
** [[Rhinovirus]] |
||
* Fungi |
* Fungi |
||
** ''Cryptococcus'' spp. |
** ''[[Cryptococcus]]'' spp. |
||
** ''Histoplasma capsulatum'' |
** ''[[Histoplasma capsulatum]]'' |
||
** ''Coccidioides'' |
** ''[[Coccidioides]]'' |
||
* Clinically-important but uncommon organisms |
* Clinically-important but uncommon organisms |
||
** ''Legionella'' species |
** ''[[Legionella]]'' species |
||
** Influenza A and B, including avian influenza A H5N1 and avian influenza A H7N9 |
** [[Influenza]] A and B, including avian influenza A H5N1 and avian influenza A H7N9 |
||
** MERS-CoV and severe acute respiratory syndrome coronavirus (SARS-CoV) |
** [[MERS-CoV]] and [[severe acute respiratory syndrome coronavirus]] (SARS-CoV) |
||
** Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) |
** Community-associated methicillin-resistant [[Staphylococcus aureus]] (CA-MRSA) |
||
== Clinical Presentation == |
== Clinical Presentation == |
||
Revision as of 00:00, 3 October 2019
Microbiology
- Bacteria
- Typical organisms
- Streptococcus pneumoniae
- Haemophilus influenzae
- Staphylococcus aureus
- Group A streptococci
- Moraxella catarrhalis
- Anaerobes and aerobic gram-negative bacteria
- Atypical organisms
- Others
- Typical organisms
- Viral
- Fungi
- Clinically-important but uncommon organisms
- Legionella species
- Influenza A and B, including avian influenza A H5N1 and avian influenza A H7N9
- MERS-CoV and severe acute respiratory syndrome coronavirus (SARS-CoV)
- Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)
Clinical Presentation
- If effusion, consider Legionella
Investigations
- Always add Legionella testing in immunocompromised, critical illness, recent travel, significant alcohol, and consider when pleural effusion is present
Management
Prognosis
Further Reading
References
- ^ Joshua P. Metlay, Grant W. Waterer, Ann C. Long, Antonio Anzueto, Jan Brozek, Kristina Crothers, Laura A. Cooley, Nathan C. Dean, Michael J. Fine, Scott A. Flanders, Marie R. Griffin, Mark L. Metersky, Daniel M. Musher, Marcos I. Restrepo, Cynthia G. Whitney. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. American Journal of Respiratory and Critical Care Medicine. 2019;200(7):e45-e67. doi:10.1164/rccm.201908-1581st.
